Inflammatory Bowel Disease and Cancers: What Connections Lie Between Them?
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 20 March 2027 | Viewed by 177
Editor
Interests: inflammatory bowel disease; ulcerative colitis; Crohn’s disease; advanced therapy; biological drugs; small molecules; non-invasive monitoring; endoscopy; histology; fecal calprotectin
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, are characterized by chronic intestinal inflammation and an increased risk of both intestinal and extra-intestinal malignancies. The complex interplay between persistent inflammation, immune dysregulation, genetic susceptibility, environmental factors, and long-term therapeutic exposure is increasingly recognized as a key driver of cancer development in IBD patients. This Special Issue aims to provide a comprehensive and up-to-date overview of the links between IBD and cancer, spanning epidemiology, pathophysiological mechanisms, risk stratification, surveillance strategies, and preventive approaches. Particular emphasis will be placed on the impact of advanced therapies, including biologics and small molecules, as well as the role of endoscopic, histological, and non-invasive monitoring tools. Original research articles, reviews, and meta-analyses addressing clinical and translational aspects are welcome.
Dr. Ferdinando D'Amico
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- Crohn’s disease
- ulcerative colitis
- cancers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
